AUA2023 TAKE HOME MESSAGES Reflections on AUA2023: Prostate Cancer
JU INSIGHT Free PSA and Clinically Significant and Fatal Prostate Cancer in the PLCO Screening Trial
UPJ INSIGHTTrends in Prostate-specific Antigen Screening for US Men With a Family History of Prostate Cancer
AUA2023 BEST POSTERSLong-term Tumor Necrosis Factor–alpha Inhibitor Use Decreases the Risk of Prostate Cancer
PROSTATE CANCERTestosterone Replacement After Definitive Prostate Cancer Treatment: Where Do We Stand?
PROSTATE CANCERRandomized Controlled Trials to Inform Prostate Biopsy Debate
JU INSIGHTDiagnostic 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence
AUA2023 BEST POSTERSBaseline Prostate Health Index Risk and Changes During Active Surveillance Predict Grade Reclassification
Personalized Prostate Cancer Risk Assessment With an Integrated Biomarker and Magnetic Resonance Imaging Approach
Healthy Men Should Undergo Baseline PSA Screening: A Call for Clear Guidance
SPECIALTY SOCIETIES Paradigm Shifts in the Diagnostic Pathway for Prostate Cancer in Accordance With Evolving Technology
AUA2022: BEST POSTERS SelectMDx and Multiparametric Magnetic Resonance Imaging Improve the Diagnostic Workup for the Detection of Prostate Cancer in Biopsy-naive Men
AUA2022 PRESENTATION: Urological Care for the Advanced Practice Provider Program. Prostate Cancer Biomarkers: What to Choose and When to Use
AUA2022 COURSE: Incorporating Genomic Testing for Prostate Cancer into Your Practice
AUA2022 COURSE: Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection and Management of Localized and Advanced Disease
AUA2022: BEST POSTERS Is It Clinically and Oncologically Safe to Omit Biopsy in Low-Risk Stratified Patients?
AUA2022: PLENARY RECAP The Fine Frontier between High-Risk, Locally Advanced, and Oligometastatic Prostate Cancer
AUA2022: PLENARY RECAP Clinical Utility of Prostate-Specific Membrane Antigen Diagnostics and Theranostics
RADIOLOGY CORNER The Role of Imaging on the Diagnosis of Benign Prostatic Hyperplasia versus Prostate Cancer
Ductal Prostate Cancer: What Do We Know in 2022?
Focal Therapy: For Which Patients? What’s Currently Available and What May Be Coming Soon?
JU INSIGHT: The Effect of Different Types of Prostate Biopsy Techniques on Post-Biopsy Infectious Complications
CASE REPORT: A Case of Macrocystic Ductal Adenocarcinoma of the Prostate
UPJ Insight: IsoPSA Reduces Provider Recommendations for Biopsy and Magnetic Resonance Imaging in Men with Total Prostate Specific Antigen 4 ng/ml: A Real-World Observational Clinical Utility Study
The Complicated Cost of Prostate Biopsies
Value in Health Care
Adjuvant Radiation Therapy in the Modern Management of High-Risk Prostate Cancer: Too Much Too Soon?
Prostate Cancer Biomarkers in 2022: Where Do We Stand, and Where Are We Going?
AQUA IN ACTION: Baseline Bone Density Evaluation among Men on Androgen Deprivation Therapy
UPJ Insight: Diagnostic Imaging in Low-Risk Prostate Cancer: More Harm Than Good?
AUA2021 COURSE: Common Dilemmas in Prostate Cancer Detection and Management
AUA2021 COURSE: Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease and CRPC
AUA2021 COURSE: Incorporating Genomic Testing for Prostate Cancer into Your Practice
AUA2021 PLENARY: Highlights Summary of the State-of-the-Art Lecture on: Personalized Medicine in the Management of Prostate Cancer across the Patient Care Continuum
Post-Prostatectomy Questionnaires: Which is Best?
Active Surveillance: What is the Schedule You Tell Your Patient?
JOURNAL BRIEFS Urology Practice: The Effect of 5-ARI Use on PSA Remains Unaccounted for When Initially Assessing Prostate Cancer Risk
CASE REPORT: The Novo Small Cell Neuroendocrine Carcinoma of the Prostate: An Aggressive Variant of Prostate Cancer
Journal Briefs: The Journal of Urology: Specific Detection of Prostate Cancer Cells in Urine by RNA In Situ Hybridization
Journal Brief: The Journal of Urology: OSPREY: A Phase 2/3 Study of the Diagnostic Accuracy of 18 F-DCFPyL-PET/CT in Prostate Cancer Patients
Have You Read? February 2021
BRCA Mutations in Prostate Cancer: What Do I Need to Know?
CASE Report: Prostate Cancer Cryoablation with Real-Time Digital Biopsy Using a Novel Fluorescence Confocal Microscope
NEW Technologies: In-Office Ultrasound-Guided Transperineal Prostate Biopsy